BTS
TGTX icon

BB&T Securities’s TG Therapeutics TGTX Stock Holding History

BB&T Securities’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-16,650
Closed -$218K – 1643
2018
Q2 		$218K Sell
16,650
-5,700
-26% -$78.4K ﹤0.01% 1418
2018
Q1 		$317K Sell
22,350
-11,350
-34% -$145K ﹤0.01% 1216
2017
Q4 		$276K Buy
33,700
+20,400
+153% +$178K ﹤0.01% 1217
2017
Q3 		$157K Sell
13,300
-3,649
-22% -$41.6K ﹤0.01% 1324
2017
Q2 		$170K Buy
16,949
+6,549
+63% +$73.3K ﹤0.01% 1312
2017
Q1 		$121K Buy
+10,400
New +$74.7K ﹤0.01% 1206

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $30.6B AUM